Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2026-01-22 @ 1:14 PM
Study NCT ID:
NCT06365593
Status:
COMPLETED
Last Update Posted:
2025-05-25
First Post:
2024-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
hATTR Polyneuropathy in Russia
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hereditary Transthyretin Amyloidosis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | hATTR | View |
| None | CIAP | View |
| None | hATTR-PN | View |
| None | ATTR-PN | View |
| None | ATTRv | View |
| None | ATTR | View |
| None | polyneuropathy | View |
| None | transthyretin amyloid polyneuropathy | View |
| None | chronic idiopathic axonal polyneuropathy | View |
| None | hereditary transthyretin amyloidosis | View |